ArticleInternational journal of hematology2022

A case series of patients treated with inotuzumab ozogamicin for acute lymphoblastic leukemia relapsed after allogeneic hematopoietic cell transplantation.

Akihiko Izumi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.